Cleopatra “Cleo” Cabuz

2025 Inductees

Cleopatra “Cleo” Cabuz, Ph.D.

Vice President of Technology and Partnerships (Retired)
Honeywell Safety and Productivity Solutions

59 U.S. Patents

Cleopatra “Cleo” Cabuz, Ph.D., is the retired Vice President of Technology and Partnerships for Honeywell’s Safety and Productivity Solutions, a $6 billion division of Honeywell International. In this role, she was instrumental in steering the division’s advanced technology portfolio, accelerating innovation, and fostering strategic partnerships. Prior to this, she served as Vice President of Engineering and Chief Technology Officer for Honeywell’s Industrial Safety business. Over her 23-year tenure at Honeywell, Dr. Cabuz progressed from Principal Research Scientist in Honeywell Corporate Labs to various leadership roles, consistently driving technological advancement.

With a career spanning both industry and academia, Dr. Cabuz has made significant contributions to engineering research, capability development, and leadership. Her work on Micro-Electro-Mechanical Systems (MEMS) actuators led to the invention of a new family of ultra-low-power, cost-effective, polymer-based electrostatic actuators with rolling contacts. These innovations have been pivotal in developing valves, pumps, and artificial muscles used in advanced medical technologies. Notably, her design of rolling contacts reduced actuation voltage requirements while enhancing displacement and stability. Her extensive patent portfolio includes groundbreaking structures such as the Dual Diaphragm Pump, Active Surfaces, and the Artificial Muscle.

Dr. Cabuz’s research also extended into integrated systems for chemical and biological analysis. She led multidisciplinary teams in developing and demonstrating systems like the MesoSniffer, a portable landmine detection device, and the Micro Cytometer for blood analysis. She invented and demonstrated the first handheld flow cytometer capable of performing complete blood counts, a test conducted approximately two billion times annually worldwide. Her innovations in miniaturized flow cytometry, including disposable cartridges, laid the foundation for the ImmuneIQ product line, enabling point-of-care diagnostics for immune diseases.

Dr. Cabuz holds 59 U.S. patents. In 2017, she was elected to the National Academy of Engineering for her contributions to sensors, MEMS technologies, and the development of industrial and safety products. She served as Executive Director of the MEMS Industry Group from 2003 to 2005 and is an elected Senior Member of the Institute of Electrical and Electronics Engineers (IEEE). Her numerous honors include Honeywell’s 2000 Technical Achievement Award, the 2003 Lion’s Award, and the 2011 Velocity Product Development Award. She is an inductee of both the MEMS Industry Group Hall of Fame and Honeywell’s Inventor’s Hall of Fame. In 2018, Newsweek Romania recognized her as one of the “Top 100 Romanians from Abroad” during Romania’s Centennial celebrations.

Dr. Cabuz holds an M.S. in Electronics from Politehnica University of Bucharest in Romania and a Ph.D. in Mechatronics/Microsystems Engineering from Tohoku University in Japan.

Michael P. Francis

2025 Inductees

Michael Francis

Michael P. Francis, Ph.D.

Associate Professor of Orthopedic Surgery and Sports Medicine
University of South Florida Morsani College of Medicine
CEO, Asante Bio

25 U.S. Patents

Michael P. Francis, Ph.D. is an Associate Professor of Orthopedic Surgery and Sports Medicine at the University of South Florida’s Morsani College of Medicine. He is also the CEO and founder of Asante Bio, a Florida-based biomanufacturing company focused on advancing regenerative medicine and orthopedic medical devices.

Over the course of his career, Dr. Francis has made transformative contributions to the field of regenerative medicine and musculoskeletal health, developing, patenting, and commercializing numerous innovations that are used in the treatment of common orthopedic and spinal conditions. His groundbreaking work includes the invention of bioengineered implants and regenerative biomaterials, which have significantly advanced the treatment of conditions such as rotator cuff repair, spinal fusion, ACL regeneration, and pediatric musculoskeletal disorders. These technologies are used by hundreds of clinicians and have benefited millions of patients, improving surgical outcomes and enhancing quality of life. Among his most notable commercialized inventions are Tapestry™ for rotator cuff regeneration and ActiBraid™ for ACL repair, both now considered industry standards.

As co-founder and Chief Scientific Officer of Embody, Inc., Dr. Francis developed groundbreaking technologies, including the first-ever microfluidic collagen suture and electrospun orthopedic implants. These technologies represent significant advancements in the field of musculoskeletal repair, with wide-reaching clinical implications for millions of patients annually. In 2023, Embody was acquired by Zimmer Biomet for $275 million, one of the largest recent exits in the life sciences sector.

Beyond his technical expertise, Dr. Francis has demonstrated exceptional leadership in advancing biomedical research and entrepreneurship. His work has brought together cutting-edge research, patenting, commercialization, and venture funding to produce practical, life-saving medical solutions. Notably, Dr. Francis’ innovative research has secured more than $30 million in private funding and over $25 million in federal grants, enabling the development and commercialization of next-generation biomedical technologies. He is actively involved in national and international standards committees and lectures widely on inventorship, entrepreneurship, and biomanufacturing.

Dr. Francis holds 25 U.S. Patents and is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). He also serves on various advisory boards and committees, contributing to the advancement of medical technologies and standards.

Dr. Francis received a joint Ph.D. from the University of Virginia, Charlottesville and Virginia Commonwealth University, Richmond in Pathology & Molecular Medicine. He went on to complete his post-doctoral training in Biomedical Engineering & Regenerative Medicine at LifeNet Health Institute for Regenerative Medicine.

Nasser Kutkut

2025 Inductees

Nasser Kutkut

Nasser Kutkut, Ph.D., D.B.A.

Founder and CEO
Smart Charging Technologies, LLC
Graduate Faculty Scholar
University of Central Florida

20 U.S. Patents

Nasser Kutkut, Ph.D., D.B.A., is the founder and CEO of Smart Charging Technologies LLC, a high-tech firm based in Orlando, Florida, specializing in innovative Internet of Things (IoT) energy management solutions. He also serves as a Graduate Faculty Scholar in the Department of Electrical and Computer Engineering at the University of Central Florida and mentors emerging entrepreneurs through UCF’s Business Incubation Program.

A trailblazing innovator in energy conversion systems, battery management, and industrial IoT technologies, Dr. Kutkut has led a prolific career spanning nearly three decades. He introduced high-frequency, high-efficiency, fast, and opportunity chargers that eliminated the need for costly and time-consuming battery change-outs. These systems are deployed across thousands of facilities by Fortune 500 companies such as General Motors, Toyota, Kraft Foods, and Estée Lauder and have saved more than $140 million in operational costs while significantly enhancing workplace efficiency.

Dr. Kutkut also pioneered the industry’s first line of industrial IoT-enabled battery chargers and monitoring systems, delivering substantial energy savings and reductions in carbon emissions for clients including Amazon Air, Coca-Cola, and Walmart. He further led the development of the first cloud-based application for remote monitoring and control of industrial battery charging assets, ushering in a new era of smart, connected energy infrastructure.

Earlier in his career, Dr. Kutkut co-invented soft-switching DC-to-DC converters and high-efficiency transformer designs—technologies that have become foundational in modern power electronics. To date, more than 72,000 industrial charging systems based on his patented innovations have been deployed worldwide, saving over 7,400 megawatt-hours of energy and eliminating more than 11 million pounds of CO₂ emissions. His contributions have helped organizations improve efficiency, reduce costs, and operate more sustainably.

A serial entrepreneur, Dr. Kutkut has founded multiple high-impact ventures, including Power Designers LLC, Verdant Energy Service LLC, and Smart Charging Technologies LLC. All of his companies, including Smart Charging Technologies, are industry leaders for pioneering advances in electric vehicle charging and intelligent battery management systems.

Dr. Kutkut holds 20 U.S. patents spanning breakthrough innovations in power electronics, modular charging architectures, adaptive solar tracking, and cloud-based fleet and battery monitoring systems. In 2001, he placed among the top three in the U.S. Department of Energy’s Future Energy Challenge.

Dr. Kutkut earned a B.Sc. in electrical engineering from the Jordan University of Science and Technology, and an M.Sc. in electrical engineering from the University of Illinois at Chicago. He completed a Ph.D. in electrical engineering and an M.B.A. in management and entrepreneurship at the University of Wisconsin–Madison. He later earned a Doctorate in Business Administration in entrepreneurship and marketing from Grenoble École de Management in Grenoble, France.

Sumita B. Mitra

2025 Inductees

Sumita Mitra

Sumita B. Mitra, Ph.D.

Professor, Institute for Advanced Discovery & Innovation
University of South Florida
Partner, Co-Owner
Mitra Chemical Consulting, LLC
Corporate Scientist, Retired
3M

100 U.S. Patents

Sumita Mitra, Ph.D. is a Professor in the Institute for Advanced Discovery & Innovation at the University of South Florida. She is also Partner and Co-Owner of Mitra Chemical Consulting LLC, an independent firm she co-founded following her retirement from 3M Company. At 3M, she served as a Corporate Scientist in the Dental Products Division for over 30 years, leading pioneering efforts in the development of advanced dental materials.

An internationally recognized pioneer, Dr. Mitra innovated groundbreaking applications of nanotechnology to dental composites advancing both clinical practice and material science, and enabling the creation of products that have improved dental outcomes worldwide. Most notably, her innovation, 3M™ Filtek™ Supreme Universal Restorative, introduced in 2002, marked a major advancement in restorative dentistry. It was the first to use a novel class of nanoparticle composites that combined superior aesthetics with exceptional mechanical strength and durability. Prior to this breakthrough, dental composites were limited by issues such as shrinkage, poor polish retention, and reduced strength over time. Since its launch, Filtek™ has been used in well over one billion restorations globally, a testament to its transformative impact. Dr. Mitra’s visionary work also contributed to revolutionary technologies in resin-modified glass ionomers, and led to other breakthrough products including Vitrebond™, Vitremer™, RelyX™ Luting Cements, Scotchbond™ Multipurpose, and APC™ Orthodontic Adhesive.

Dr. Mitra was the first to create and introduce a stable, high-load nanocluster filler system. By engineering these nanoclusters, she and her team enabled significantly increased filler loading without compromising viscosity or workability. This innovation allowed clinicians to place and sculpt composites with greater ease while delivering long-term mechanical performance in the oral environment. Her work also had a transformative effect on adhesive technology in dentistry, contributing to materials that bonded more effectively to tooth structures and maintained their bond over time. These innovations not only set new benchmarks in the industry, but also enabled restorative procedures to become less invasive, more reliable, and longer lasting.

From 1999 to 2010 she served as the Industrial Directore of Minnesota Dental Resarch Center of Biomechanics and Biomaterials at the University of Minnesota. Since 2015 she is a member of the Association of Senior Professionals at Eckerd College (ASPEC) in St. Petersburg, Florida which is dedicated to lifelong learning where she co-chairs a forum on “Science and Society” and interacts with faculty and students.

Dr. Mitra holds 100 U.S. patents. She is a Member of the National Academy of Engineering and a Fellow of the National Academy of Inventors. She was inducted into the National Inventors Hall of Fame in 2018 and received the prestigious European Patent Office Inventor Award in 2021. Her other honors include the American Chemical Society Heroes of Chemistry Award, the Peyton-Skinner Award for Innovation in Dental Materials, and the Hollenback Memorial Prize from the Academy of Operative Dentistry.

Dr. Mitra received a B.Sc. in Chemistry from Presidency College in India, an M.Sc. in Organic Chemistry from the University of Calcutta, and a Ph.D. in Organic/Polymer Chemistry from the University of Michigan.

Subhra Mohapatra

2025 Inductees

Subhra Mohapatra, Ph.D.

Professor, Molecular Medicine
University of South Florida
Research Career Scientist
James A. Haley Veterans Hospital

27 U.S. Patents

Subhra Mohapatra, Ph.D., is a Professor of Molecular Medicine at the University of South Florida (USF) Morsani College of Medicine and a Research Career Scientist at the James A. Haley Veterans’ Hospital in Tampa, Florida. She is also the co-founder of Transgenex Nanobiotech, a company focused on cancer stem cell-targeted therapeutics, and the co-founder of Agile Diagnostics (ADX), Inc., which develops rapid diagnostic technologies.

With an interdisciplinary background in chemistry, immunology, and molecular engineering—and a career spanning more than 25 years—Dr. Mohapatra has built a world-class research program at USF and the VA. Her work has significantly advanced cancer research, regenerative medicine, and neurotherapeutics, helping shape the evolving landscape of precision medicine. Most notably, Dr. Mohapatra’s pioneering nanofiber-based tumoroid culture systems—including tumor-on-a-disc and the four-dimensional perfused tumor-on-a-chip technologies—have revolutionized how cancer is modeled in the lab, offering new hope for personalized treatments. These platforms allow for the growth of patient-derived tumors that retain the genetic and pathological features of the original cancer, enabling precise testing of therapies tailored to individual tumor profiles.

In addition to transforming translational bench-to-bedside cancer research, Dr. Mohapatra’s scientific innovations extend to complex neurological disorders and public health crises. She developed a novel nose-to-brain nanodrug delivery system with potential applications for brain tumors and neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s disease. Her research was among the first to demonstrate how COVID-19 (SARS-CoV-2) infection may influence gene expression associated with Alzheimer’s disease, illuminating the potential long-term neurological consequences of COVID-19.

Beyond her academic research, Dr. Mohapatra is also an inventor-entrepreneur. As co-founder of Agile Diagnostics (ADX), Inc., she led the development of a game-changing, ultra-rapid detection technology that is capable of detecting viral antigens, including COVID-19, in under a minute. Unlike traditional antibody-based tests, this system boasts high sensitivity and resilience against emerging variants, with the potential to transform diagnostic access globally. She also founded Transgenex Nanobiotech to advance cancer stem cell-focused therapeutics and diagnostics, translating her discoveries into technologies that are actively shaping cancer drug development, delivery, and testing.

Dr. Mohapatra holds 27 U.S. Patents. She is an elected Fellow of the American Association for the Advancement of Science (AAAS), the American Institute for Medical and Biological Engineering (AIMBE), and the National Academy of Inventors (NAI). She has received numerous awards, including multiple VA Merit Review Awards and the prestigious Biomedical Laboratory Research and Development (BLR&D) Research Career Scientist Award in 2018. She also serves as Academic Editor for PLOS One, and she was awarded the PLOS One Editorial Board Long Service Award in 2023.

Dr. Mohapatra earned her B.S. and M.S. in Chemistry from Utkal University in India. She received a Master’s in Information Systems (M.I.S.) from McGill University in Canada and completed her Ph.D. in Immunology at the University of Manitoba.

Edward Rosenthal

2025 Inductees

Edward Rosenthal, D.Sc. (h.c.)

Founder and President
Florikan ESA

7 U.S. Patents

Edward Rosenthal, D.Sc. (h.c.) is the Founder and President of Florikan ESA, a pioneering agricultural company headquartered in Sarasota, Florida. With over four decades of leadership in sustainable agriculture and controlled-release fertilizer technologies, Dr. Rosenthal has grown Florikan into a nationally recognized innovator, developing breakthrough solutions that have transformed fertilization practices for commercial growers, homeowners, and NASA scientists alike.

Dr. Rosenthal earned his bachelor’s degree from Concordia University (formerly Sir George Williams University) in Montreal, Canada.

Dr. Rosenthal’s landmark innovations in controlled-release fertilizer technology addressed a fundamental flaw in conventional fertilization: nutrient inefficiency and environmental runoff. Recognizing that traditional fertilizers often lead to significant waste and pollution, he developed Staged Nutrient Release™ fertilizer (SNR) technology, a novel system that delivers essential nutrients in sync with plant growth cycles. By encapsulating nitrogen, phosphorus, and potassium separately and blending them into custom formulas, Dr. Rosenthal created a single, efficient product tailored to plant development. This innovation has significantly reduced fertilizer use and nutrient leaching, while improving crop yield and resource efficiency, advancing both agricultural sustainability and environmental protection, particularly in sensitive ecosystems like Florida’s waterways.

A trained polymer chemist, Dr. Rosenthal also identified the potential for SNR applications in space. In 2014, he began collaborating with NASA’s Space Crop Production team to develop fertilizer formulations for use aboard the International Space Station (ISS). His contributions were instrumental in optimizing plant growth in NASA’s Veggie and Advanced Plant Habitat experiments, which now rely on Florikan fertilizers to grow leafy greens, tomatoes, peppers, wheat, and other crops. These controlled-release formulations provide precise nutrient delivery in the confined, resource-limited environments of space, offering a critical solution for sustaining life on future missions to the Moon, Mars, and beyond. Florikan’s SNR technology is now the sole fertilizer used on the ISS as part of NASA’s Veggie program.

Beyond the laboratory, Dr. Rosenthal is a certified Space Educator and passionate advocate for STEM education. He has helped bridge the gap between advanced science and classroom learning, reinforcing his role not just as an inventor, but as a visionary leader in the future of agriculture. Through partnerships with programs like the Fairchild Tropical Botanic Garden’s Growing Beyond Earth initiative, Dr. Rosenthal has empowered tens of thousands of students nationwide to engage with real-world space and agricultural science.

Dr. Rosenthal holds seven U.S. patents, and he has been recognized with numerous awards, including the National Society of Professional Engineers Award. In 2017, he and Florikan, in collaboration with NASA KSC and SATOP, were inducted into the Space Technology Hall of Fame for the development of the encapsulated Staged Nutrient Release Fertilizer. Dr. Rosenthal and Florikan were also recognized as one of NASA’s leading technology transfer innovations and were featured in two issues of NASA Spinoff magazine in 2017 and 2018. Concordia University awarded him an Honorary Doctorate in 2023 in recognition of his lasting impact on agritechnology and environmental sustainability.

Dr. Rosenthal earned his bachelor’s degree from Concordia University (formerly Sir George Williams University) in Montreal, Canada.

W. Greg Sawyer

2025 Inductees

W. Greg Sawyer, Ph.D.

Chief BioEngineering Officer
Chair, Department of BioEngineering
Moffitt Cancer Center

43 U.S. Patents

W. Gregory Sawyer, Ph.D., is the Chief BioEngineering Officer and Chair of the Department of BioEngineering at Moffitt Cancer Center in Tampa, Florida. Before joining Moffitt, he served as the N. C. Ebaugh Chair and Distinguished Teaching Scholar at the University of Florida, where he spent more than two decades advancing research and education in mechanical engineering, materials science and biomedical innovation.

Dr. Sawyer is an internationally recognized researcher, inventor and entrepreneur whose innovations have made transformative impacts across biomedical engineering, materials science, advanced manufacturing and aerospace. As an innovator in tribology and biomechanics, he has developed technologies ranging from space-qualified polymeric nanocomposites and low-friction materials for extreme environments to high-performance contact lenses that improve patient comfort and health. Dr. Sawyer pioneered the field of Cancer Engineering, which combines different disciplines in engineering and the physical sciences to advance the research infrastructure in both academia and industry.

In ophthalmology, Dr. Sawyer’s groundbreaking work in lubricity introduced a new paradigm in contact lens technology, defining the role of shear-stress on inflammation and discomfort. His hydrogel patents detail the science behind the creation of surfaces that significantly reduce shear stress, improve lubricity, and comfort. These innovations are now integral to contact lens design and products.

Dr. Sawyer’s work in biomaterials and biomechanics is equally impactful. His patents in prosthetics and orthopedic devices have revolutionized the design and performance of implants, often leveraging flexure mechanisms to reduce sliding and wear, significantly enhancing the durability of prosthetic joints and spinal implants.

A trailblazer in bio-manufacturing and regenerative medicine, Dr. Sawyer’s work has transformed cancer research and pioneered the field of cancer engineering. Under his leadership, his laboratory invented 3D perfusion systems that enable the preservation and culture of patient micro-tumors and micro-tissues used in precision medicine, drug screening, immuno-oncology studies, and cancer biology. His patents and inventions in freeform 3D bioprinting and multifunctional microgel materials have enabled a comprehensive suite of technologies for cancer biology and drug discovery that are used by major pharmaceutical companies and leading research universities and cancer centers across the country. These innovations led to the creation of spin-out companies, including Aurita BioScience, a Florida-based startup he founded.

Dr. Sawyer holds 43 U.S. patents. He is a Fellow of the National Academy of Inventors and recipient of the Tribology Gold Medal, the highest international honor in his field. His other honors include the BioFlorida Entrepreneur of the Year Award, and the Burt L. Newkirk and Marshall B. Peterson Awards from the American Society of Mechanical Engineers.

He earned his B.S., M.S. and Ph.D. in mechanical engineering from Rensselaer Polytechnic Institute.

Sylvia Wilson Thomas

2024 Inductees

Sylvia Wilson Thomas

Sylvia Wilson Thomas, Ph.D.

Vice President for Research & Innovation
President & CEO, Research Foundation
University of South Florida

13 U.S. Patents

Sylvia Wilson Thomas, Ph.D. is the Vice President for Research & Innovation at the University of South Florida and President & CEO of the USF Research Foundation, Inc. As a member of the USF president’s and provost’s cabinets, Dr. Thomas directs, manages, and provides vision for USF’s $690M+ research and innovation enterprise. Dr. Thomas also serves as a Professor of Electrical Engineering at USF’s College of Engineering where she leads the Advanced Membrane and Materials Bio and Integration Research laboratory for biomedical, biological, and nano electronic device integration using advanced material systems for membrane technology.

Dr. Thomas’s transformational innovations in miniaturized electronic circuitry and devices and nanotechnologies for sensing applications has opened new pathways for bio and nano electronic device integration using advanced membrane/material systems to meet global technological challenges. Her novel developments, from implantable health monitoring devices to the frontier of wearable electronics, have broad applications from health care to the military.

Prior to joining USF, Dr. Thomas was a research scientist at leading industry companies such as Kimberly Clark Corp, IBM, and Procter & Gamble, and most notably at Bell Labs/Agere Systems/Lucent Technologies, where she began her groundbreaking research in implantable microelectronics.

Dr. Thomas is a Fellow of the American Institute for Medical and Biological Engineering, Fellow of the National Academy of Inventors and Senior Member of the Institute of Electrical and Electronics Engineers. She is also the recipient of the 2020 Black Engineer of the Year (BEYA) STEM Educational Leadership Award. Her creative, current affairs-driven projects have been supported by a wide range of funders, from USF seed grants to the National Science Foundation for over $4.8M.

Dr. Thomas also serves as the president of the IEEE’s Engineering in Medicine and Biology Florida West Coast Section; Secretary/Treasurer of the Florida Education Fund; former advisor for the Society of Women Engineers, Society of Hispanic Professional Engineers, and National Society of Black Engineers; and an inaugural member of the Board of Directors for Black Girls Code. She is the recipient of the 2023 Top 50 Women Leaders in Education, and 2022 Florida Trend 500 Most Influential Business Leaders.

Dr. Thomas holds B.S. and M.S. degrees in electrical engineering from Vanderbilt University, where she was a Patricia Roberts Harris Fellow, and earned her Ph.D. in electrical engineering from Howard University as an NSF Materials Research Center of Excellence Fellow.

Greg Mesaros

2024 Inductees

Greg Mesaros

Greg Mesaros, MBA

Chief Executive Officer and Chair
Triadex

45 U.S. Patents

Greg Mesaros is the Chief Executive Officer and Chair of Triadex, an award-winning, data-driven marketing firm he founded over 20 years ago that leverages proprietary data analytics and AI-ML to unlock key growth drivers for businesses. He owns additional companies in the marketing and data sectors, with several listed on Inc. Magazine’s 500/5000 Fastest Growing Private Companies List.

Mr. Mesaros founded his first technology company in 1999 and just one year later was successful in commercializing the first seller-initiated social buying platform. In that same year, he filed his initial patent application that has yielded 45 patents across 10 patent families in such diverse categories as e-commerce, dynamic pricing, mobile devices, predictive analytics, social networks, and location-based marketing. His patents have been cited in numerous patent applications by such companies as Amazon, Google, Microsoft, American Express, eBay, IBM, among others, and he has licensed his inventions to companies across diverse industries.

Mr. Mesaros has served on the board of several non-profits and was a member of the External Advisory Corporate Board for the University of South Florida’s Office of Corporate Partnerships. In 2007, he and his wife, Sonia, founded their family charitable trust supporting local and international charities. His company started the industry’s first Environmental Offset Program that provides funding for the National Forestry Foundation and the Gold Standard Foundation. The program champions equitable, science-based policies that remove carbon directly from the environment through moonshot technologies. His company awards annual scholarships for first generation college students working towards degrees in STEM, entrepreneurship, and business. As a thought leader, Mr. Mesaros frequently shares his insights as a guest speaker at universities. His interactions with students aim to inspire a future generation of inventors and entrepreneurs.

Mr. Mesaros has been recognized for his significant contributions to advancing new technology, including awards ranging from the TechKnow and Manny Awards, to being selected by the State of Ohio, where his company was originally founded, for the E-Commerce Pioneer Award. Mr. Mesaros was named a Top 50 Tampa Business Leader and Purchasing Magazine named him one of the top 40 e-procurement visionaries in the country. Mr. Mesaros earned a B.S. in Business Administration from Bowling Green State University. He went on to graduate Beta Gamma Sigma with an MBA from Loyola Marymount University.

A MENTION ABOUT INVENTION – 3 Questions for the Inventor

Q1. Of your patents/inventions, which one is your favorite and why?

While I value all my patents, one stands out for its uniqueness and how it almost didn’t get filed. Patent number 8573492, titled “Presenting Offers to a Mobile Device Associated with Information Displayed on a Television,” was part of a larger theme dating back to patents originally filed in 2003, but it was completed as part of a continuation of mobile device patents. When I first conceived the idea of someone holding a mobile device and interacting with images on a television, my initial thought was, “Who would actually do that?” That moment could have ended the invention right there—my inner critic nearly won. However, I took the time to explore potential applications and address each critique. I saw how the concept could be applied, and even though I wasn’t convinced at the time that it would ever be commercialized, I decided to file the patent.

That’s the thing about filing patents: you often don’t know the commercial value upfront. Only time will reveal whether it becomes part of the commercial ecosystem. Fast forward several years, and a well-known, publicly traded company reached out through their representative, seeking to purchase that very patent for an application they were developing. Instead, we agreed to license the technology.

Q2. What inspired you to become an inventor/innovator?

I have always been curious about the world around me. As a child, I loved reading, especially autobiographies. I was inspired by individuals who not only saw the world as it was but also sought to change it for the better. In college, I decided to focus on the intersection of technology, marketing, and finance. I took as many graduate-level courses as possible and consumed technical and business journals. This preparation gave me a unique framework across all three disciplines, which I was able to apply when the internet came into existence.

Invention starts with the belief that you have a better way. The next step is finding sustained enthusiasm to weather the tough times and see your invention through to completion. It takes an immense amount of effort to create something new, and it is equally challenging to know when to end that invention. There is a certain amount of listening to your inner voice that comes into play, and you must assess which concept has more room to run. Trust your gut. With your time being finite, it’s essential to pick your area of focus, apply all your effort and ingenuity, and remain persistent in producing the absolute best solution. As Thomas Edison famously said, it’s far more about hard work than the initial spark of inspiration. In short, persistence and the ability to remain open to the possibilities are key to inventing.

Q3. What is your process when developing new inventions/innovations?

As a sole inventor, you don’t have the luxury of bouncing ideas off a team. While there’s value in collaboration and feedback for revisions, I find it best to work through the initial concept on my own. You must improvise to ensure your ideas are realistic and marketable. One method I use is to “go with the flow.” When I’m excited about an invention, I harness that optimism to explore all the possibilities of how it could be used. I often sketch my ideas on whiteboards, sometimes for days or even weeks. Then I return to them to gauge my level of enthusiasm. If I’m less optimistic about the invention’s viability, rather than dismiss the concept outright, I channel that energy into listing every reason it might not work. I document every shortcoming and identify what is missing for it to succeed commercially. Later, when I’m in a more positive state of mind, I tackle each negative point, finding improvements or workarounds for the invention’s limitations. This process of iteration—alternating between enthusiasm and skepticism—can be time-consuming, but the final product is worth it. By the time I file the first patent, the invention not only solves a real problem but also addresses many anticipated limitations.

Daniel Yeh

2024 Inductees

Daniel Yeh

Daniel H. Yeh, Ph.D.

Professor, Civil & Environmental Engineering
University of South Florida

9 U.S. Patents

Daniel H. Yeh, Ph.D. is Professor of Environmental Engineering in the Department of Civil and Environmental Engineering at the University of South Florida, where he leads the Membrane Biotechnology Lab. Dr. Yeh also serves as a Visiting Professor at NASA Kennedy Space Center.

Dr. Yeh is an international leader in the areas of wastewater engineering and recycling; sustainable and resilient infrastructure; renewable bioenergy; global WaSH (water, sanitation, and hygiene); and life support systems for space travel. Dr. Yeh’s research efforts over the past two decades have focused on decentralized small systems for challenging environments at the water/energy/food nexus where sewers are not possible and safely managed drinking water is not readily available. His groundbreaking research led to the development of the NEWgenerator—a portable and self-contained, solar-powered toilet system that converts collected waste into fertilizer nutrients, renewable energy, and clean water to be used for crop irrigation and toilet flushing. The NEWgenerator operates completely off-grid, making it especially effective in areas where clean water and access to consistent power are scarce or unavailable.

Dr. Yeh’s work on the NEWgenerator began in 2011 with a Bill and Melinda Gates Foundation Grand Challenges Explorations grant and has since been deployed and tested extensively in India and South Africa—not only in informal settlements, where there is no functioning sewer system, but also in schools and housing projects. The Gates Foundation also selected the NEWgenerator to be showcased at the 2018 Reinvented Toilet Expo in Beijing, China.

Additionally, Dr. Yeh and his team launched the start-up company, BioReNEW, Inc., and have collaborated with industry partners worldwide to commercially produce and deploy the NEWgenerator. His inventions also include ICARUS, a floating membrane bioreactor for growing microalgae for biofuel using wastewater as a feedstock. Dr. Yeh is also working with collaborators at NASA to develop innovative wastewater treatment systems for the Artemis Program to establish permanent human presence on the Moon and eventually Mars.

A pioneer in his field, Dr. Yeh has secured over $13M in research funding and has received accolades across industry and academia for his breakthrough technologies, including the 2024 prestigious Association of University Technology Managers Better World Project Award. His work was also recognized by the US Patent and Trademark Office with the Patents for Humanity Award in 2020 and was highlighted in MIT Technology Review’s 10 Breakthrough Technologies of 2019. Additionally, in 2014, the NEWgenerator came in first place for the Cade Museum Prize for Innovation competition. Dr. Yeh is a Senior Member of the National Academy of Inventors and was selected by the American Academy of Environmental Engineers and Scientists as the 2023 Stanley E. Kappe Distinguished Lecturer to tour U.S. universities and share his invention journey of the NEWgenerator with other faculty and students. Dr. Yeh received his undergraduate and graduate degrees from the University of Michigan; earned his Ph.D. from Georgia Institute of Technology; and conducted postdoctoral research at Stanford University. He is a professional engineer, board certified environmental engineer, and a LEED accredited green building professional.